Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol versus sevoflurane anesthesia in partial hepatectomy
ChiCTR2400093457Phase 4Not yet recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Dec 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol and sevoflurane in hepatic disease (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoints: Serum alanine aminotransferase level, Serum aspartate aminotransferase level and 5 more. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
ciprofolsevoflurane
03
Conditions
hepatic disease
Beyond the preview
Go deeper on ChiCTR2400093457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093457.